Infections
| Category . | Study participants . | . | ||||
|---|---|---|---|---|---|---|
| Total . | Before neutrophil engraftment . | Days 0-29 . | Days 30-99 . | Days 100-180 . | Organisms . | |
| Gram-positive bacteria events | 5 | 1 | 2 | 1 | 1 | Coagulase-negative Staphylococcus, Enterococcus faecium, Staphylococcus epidermis |
| Gram-negative bacteria events | 7 | 1 | 3 | 5 | Escherichia coli, Klebsiella pneumoniae, Mycoplasma pneumoniae* | |
| Viral events | 3 | 3 | Cytomegalovirus | |||
| Fungal events | 3 | 1 | 2 | Candida albicans and glabrata, Aspergillus, Pneumocystis carinii | ||
| Total events | 18 | 2 | 5 | 10 | 3 | |
| Alive at interval start | N = 37 | N = 37 | N = 34 | N = 32 | ||
| Category . | Study participants . | . | ||||
|---|---|---|---|---|---|---|
| Total . | Before neutrophil engraftment . | Days 0-29 . | Days 30-99 . | Days 100-180 . | Organisms . | |
| Gram-positive bacteria events | 5 | 1 | 2 | 1 | 1 | Coagulase-negative Staphylococcus, Enterococcus faecium, Staphylococcus epidermis |
| Gram-negative bacteria events | 7 | 1 | 3 | 5 | Escherichia coli, Klebsiella pneumoniae, Mycoplasma pneumoniae* | |
| Viral events | 3 | 3 | Cytomegalovirus | |||
| Fungal events | 3 | 1 | 2 | Candida albicans and glabrata, Aspergillus, Pneumocystis carinii | ||
| Total events | 18 | 2 | 5 | 10 | 3 | |
| Alive at interval start | N = 37 | N = 37 | N = 34 | N = 32 | ||
Listed are the counts of new infection events during the first 180 d after HCT and the count by interval within these 180 days. The table also shows the count of patients alive (N) at the start of each interval. Organisms not captured include enterococci from stool, rectum, skin; Clostridium difficile from stool; polyomavirus virus from urine; and oral thrush.
M pneumoniae not laboratory proven.